Vitane Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 15.27 Cr
as on 24-10-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.96 Cr
as on 24-10-2024
- Satisfied Charges ₹ 35.00 Cr
as on 24-10-2024
- Revenue -68.19%
(FY 2023)
- Profit -82.48%
(FY 2023)
- Ebitda 82.50%
(FY 2023)
- Net Worth 0.54%
(FY 2023)
- Total Assets -6.99%
(FY 2023)
About Vitane Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 15.27 Cr.
The company currently has active open charges totaling ₹5.96 Cr. The company has closed loans amounting to ₹35.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vitane Pharmaceuticals Private Limited India is Ruchita Suryavanshi as COMPANY SECRETARY. Mohammed Sadiq and Mirza Baig serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PTC163987
- Company No.
163987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vitane Pharmaceuticals Private Limited offer?
Vitane Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Dietary Supplements, Physiotherapy & Rehab Aids, Rehab Splints, Rehabilitation Equipment, Rehab Braces, Nutritional Supplements, Cricket Kits, Thigh Guards.
Who are the key members and board of directors at Vitane Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ruchita Suryavanshi | Company Secretary | 11-Jul-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Sadiq  | Director | 23-Aug-2006 | Current |
| Mirza Baig | Director | 30-May-2012 | Current |
Financial Performance and Corporate Structure Insights of Vitane Pharmaceuticals.
Vitane Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.19% decrease. The company also saw a substantial fall in profitability, with a 82.48% decrease in profit. The company's net worth moved up by a moderate rise of 0.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitane Pharmaceuticals?
In 2023, Vitane Pharmaceuticals had a promoter holding of 100.01%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vitane Biologics Private Limited
Active 18 years 23 daysMohammed Sadiq, Mirza Baig and 1 more are mutual person
Intracell Therapeutics Private Limited
Active 11 years 9 monthsMohammed Sadiq and Mirza Baig are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Feb 2018 | ₹2.64 Cr | Open |
Others Creation Date: 16 Mar 2016 | ₹3.32 Cr | Open |
Others Creation Date: 20 Dec 2016 | ₹35.00 Cr | Satisfied |
How Many Employees Work at Vitane Pharmaceuticals?
Vitane Pharmaceuticals has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitane Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitane Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
